Doc Wags LLC

North East, USA

Short Summary

Doc Wags is a veterinarian-founded company producing novel products for pets and educational resources for pet owners. Our launch product is going to be the patent-pending So Fetch dog harness as well as various accessories to accompany it.

Highlights

  • Veterinarian-designed products for pets
  • Design-for-manufacture prototype is complete
  • Creating new niches in a profitable and growing pet care industry
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
US$150,000
Minimum
US$50,000
Investment Raised
N/A
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role Weekly Involvement

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 195,403 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Featured
6% raised

Trillum Eye Care Pre-IPO

South East, USA

Join this international health care group expand clinics in North America. Convertible Note pays 10% interest which converts into Stock pre-IPO. Company is targeting an IPO in the US.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

Global Pro
0% raised

Hemp with a Heart

West, USA

Our organic cannabinoid extracts have been chosen by Kevin Harrington to produce our very own DRTV commercial featuring our unique difference in the marketplace. At NOHI, we support complete healing through education, co-creation, and empowerment.

US$ 125,000

Target

US$ 500

Min per Investor

Global Pro
0% raised

New Rotator Cuff Product

North East, USA

We have issued patents for a new breakthrough technology that will greatly improve the standard of care for rotator cuff tears and at the same time reduce medical spending. This investment will bring this new product to the FDA for approval.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

load one similar proposal